112 related articles for article (PubMed ID: 8561975)
1. The gp120 envelope of HIV-1 binds peptides in a similar manner to human leukocyte antigens.
Sheikh MJ; Ongrádi J; Austen BM; Dalgleish AG
AIDS; 1995 Nov; 9(11):1229-35. PubMed ID: 8561975
[TBL] [Abstract][Full Text] [Related]
2. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
3. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
4. The gp120 envelope of HIV-1 binds and presents peptides in a similar manner to human leukocyte antigen.
Sheikh J; Souberbielle B; Westby M; Austen B; Dalgleish AG
AIDS; 1999 Sep; 13(13):1799-801. PubMed ID: 10509594
[No Abstract] [Full Text] [Related]
5. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4.
Houlgatte R; Scarmato P; el Marhomy S; Martin M; Ostankovitch M; Lafosse S; Vervisch A; Auffray C; Platier-Tonneau D
J Immunol; 1994 May; 152(9):4475-88. PubMed ID: 7512597
[TBL] [Abstract][Full Text] [Related]
6. Binding analysis of 95 HIV gp120 peptides to HLA-DR1101 and -DR0401 evidenced many HLA-class II binding regions on gp120 and suggested several promiscuous regions.
Gaudebout P; Zeliszewski D; Golvano JJ; Pignal C; Le Gac S; Borras-Cuesta F; Sterkers G
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):91-101. PubMed ID: 9052717
[TBL] [Abstract][Full Text] [Related]
7. Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells.
de Santis C; Lopalco L; Robbioni P; Longhi R; Rappocciolo G; Siccardi AG; Beretta A
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):157-62. PubMed ID: 7515259
[TBL] [Abstract][Full Text] [Related]
8. HIV gp120 plus specific peptides are recognized in a similar manner to specific HLA plus peptide by HLA-restricted antigen-specific T-cell lines.
Sheikh J; Souberbielle B; Westby M; Austen B; Dalgleish AG
Viral Immunol; 2000; 13(1):9-17. PubMed ID: 10733164
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides representing discontinuous CD4 binding epitopes of HIV-1 gp120 that induce T cell apoptosis and block cell death induced by gp120.
Howie SE; Cotton GJ; Heslop I; Martin NJ; Harrison DJ; Ramage R
FASEB J; 1998 Aug; 12(11):991-8. PubMed ID: 9707171
[TBL] [Abstract][Full Text] [Related]
10. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
[TBL] [Abstract][Full Text] [Related]
11. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.
Autiero M; Houlgatte R; Martin M; Auffray C; Guardiola J; Piatier-Tonneau D
Int Immunol; 1995 Feb; 7(2):191-7. PubMed ID: 7734415
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein.
Li T; Steede NK; Nguyen HN; Freytag LC; McLachlan JB; Mettu RR; Robinson JE; Landry SJ
J Virol; 2014 Sep; 88(17):9605-15. PubMed ID: 24920818
[TBL] [Abstract][Full Text] [Related]
13. The MHC-binding and gp120-binding functions of CD4 are separable.
Lamarre D; Ashkenazi A; Fleury S; Smith DH; Sekaly RP; Capon DJ
Science; 1989 Aug; 245(4919):743-6. PubMed ID: 2549633
[TBL] [Abstract][Full Text] [Related]
14. A gp120 HIV peptide with high similarity to HLA class II beta chains enhances PPD-specific and autoreactive T cell activation.
Pugliese O; Viora M; Camponeschi B; Cordiali Fei P; Caprilli F; Chersi A; Evangelista M; Di Massimo AM; Colizzi V
Clin Exp Immunol; 1992 Nov; 90(2):170-4. PubMed ID: 1424270
[TBL] [Abstract][Full Text] [Related]
15. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
[TBL] [Abstract][Full Text] [Related]
16. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
[TBL] [Abstract][Full Text] [Related]
17. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly.
Piatier-Tonneau D; Gastinel LN; Moussy G; Bénichou B; Amblard F; Vaigot P; Auffray C
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6858-62. PubMed ID: 1713692
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
